KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition

por Hamidi, H, Lu, M, Chau, K, Anderson, L, Fejzo, M, Ginther, C, Linnartz, R, Zubel, A, Slamon, D J, Finn, R S
Publicado 2014